You can find the annual or quarterly income statement of CAMP4 Therapeutics Corp here for insights into the performance and operational efficiency of CAMP4 Therapeutics Corp.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2023Q4
FY2023Q3
Total revenue
--795.00K
--1.50M
--858.00K
--652.00K
-100.00%0.00
--0.00
--350.00K
Revenue
--795.00K
--1.50M
--858.00K
--652.00K
-100.00%0.00
--0.00
--350.00K
Operating expenses
3.23%13.95M
--14.53M
--13.96M
8.98%14.69M
6.53%13.52M
--13.48M
--12.69M
R&D expenses
-3.57%9.36M
--10.34M
--10.15M
-6.24%10.00M
-1.19%9.70M
--10.66M
--9.82M
Depreciation, depletion, and amortization
-0.48%416.00K
--430.00K
--421.00K
808.70%418.00K
-2.79%418.00K
--46.00K
--430.00K
Operating profit
2.66%-13.16M
---13.03M
---13.10M
-4.14%-14.03M
-9.55%-13.52M
---13.48M
---12.34M
Net non-operating interest income (expenses)
Non-operating interest income
350.00%423.00K
--453.00K
--588.00K
7.21%610.00K
-86.36%94.00K
--569.00K
--689.00K
Non-operating interest expense
-66.67%2.00K
--1.00K
--3.00K
--4.00K
-40.00%6.00K
----
--10.00K
Gains from sale of securities
----
----
----
--4.00K
-40.00%6.00K
----
--10.00K
Special income (expenses)
---2.29M
----
----
----
----
----
----
Other non-operating income (expenses)
-11.29%-69.00K
---11.00K
--82.00K
274.70%145.00K
-31.91%-62.00K
---83.00K
---47.00K
Income before tax
-11.98%-15.10M
---12.59M
---12.43M
-2.22%-13.28M
-15.29%-13.48M
---12.99M
---11.70M
Income tax
--0.00
--0.00
--0.00
--0.00
----
----
----
Income after tax
-11.98%-15.10M
---12.59M
---12.43M
-2.22%-13.28M
-15.29%-13.48M
---12.99M
---11.70M
Net income from continuous operations
-11.98%-15.10M
---12.59M
---12.43M
-2.22%-13.28M
-15.29%-13.48M
---12.99M
---11.70M
Net income attributable to controlling interests
-11.98%-15.10M
---12.59M
---12.43M
-2.22%-13.28M
-15.29%-13.48M
---12.99M
---11.70M
Net income attributable to common shareholders
-11.98%-15.10M
---12.59M
---12.43M
-2.22%-13.28M
-15.29%-13.48M
---12.99M
---11.70M
Basic earnings per share
19.92%-0.55
---0.62
---0.62
-2.23%-0.68
-15.29%-0.69
---0.67
---0.60
Diluted earnings per share
19.92%-0.55
---0.62
---0.62
-2.23%-0.68
-15.29%-0.69
---0.67
---0.60
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
FAQs
What is the income statement?
The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.